Advertisement

Diagnosis of Unstable Angina Pectoris Has Declined Markedly with the Advent of More Sensitive Troponin Assays

      Abstract

      Background

      Since the arrival of the universal definition of myocardial infarction more sensitive troponin assays have been developed. How these occurrences have influenced the proportions and clinical features of the components of acute coronary syndrome have not been studied prospectively in unselected hospital patients.

      Methods

      During 2010 we evaluated all patients in whom cardiac troponin I had been measured at a single university hospital. The diagnosis of acute myocardial infarction (ST-elevation myocardial infarction [STEMI] or non-ST-elevation myocardial infarction [NSTEMI]) was established in cases of a rise and/or fall of cardiac troponin I together with cardiac ischemic features. Patients with unstable chest discomfort and cardiac troponin I values below the decision limit of myocardial infarction were diagnosed as having unstable angina pectoris. The definition of acute coronary syndrome included unstable angina pectoris, NSTEMI, and STEMI. Mortality data were obtained from the Danish Civil Personal Registration System.

      Results

      Of 3762 consecutive patients, 516 had acute coronary syndrome. Unstable angina pectoris was present in 7%, NSTEMI in 67%, and STEMI in 26%. The NSTEMI patients were older, more frequently women, and had more comorbidities than patients with unstable angina pectoris and STEMI. At median follow-up of 3.2 years 195 patients had died: 14% of unstable angina pectoris, 45% of NSTEMI, and 25% of STEMI patients. Age-adjusted log–rank statistics revealed differences in mortality: NSTEMI vs unstable angina pectoris (P = .0091) and NSTEMI vs STEMI (P = .0045).

      Conclusions

      The application of the universal definition together with the use of a contemporary troponin assay seems to have reduced the proportion of patients with unstable angina pectoris to the benefit of patients with NSTEMI. Despite this, NSTEMI patients have a sustained higher mortality than patients with STEMI.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Braunwald E.
        • Morrow D.A.
        Unstable angina: is it time for a requiem?.
        Circulation. 2013; 127: 2452-2457
        • Braunwald E.
        • Antman E.M.
        • Beasley J.W.
        • et al.
        ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
        J Am Coll Cardiol. 2000; 36: 970-1062
        • Thygesen K.
        • Mair J.
        • Giannitsis E.
        • et al.
        How to use high-sensitivity cardiac troponins in acute cardiac care.
        Eur Heart J. 2012; 33: 2252-2257
        • Newby L.K.
        • Jesse R.L.
        • Babb J.D.
        • et al.
        ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.
        J Am Coll Cardiol. 2012; 60: 2427-2463
        • White H.
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.
        Universal MI definition update for cardiovascular disease.
        Curr Cardiol Rep. 2014; 16: 492-495
        • Thygesen K.
        • Alpert J.S.
        • White H.D.
        Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction.
        Eur Heart J. 2007; 28: 2525-2538
        • Saaby L.
        • Poulsen T.S.
        • Hosbond S.
        • et al.
        Classification of myocardial infarction: frequency and features of type 2 myocardial infarction.
        Am J Med. 2013; 126: 789-797
        • Saaby L.
        • Poulsen T.S.
        • Diederichsen A.C.P.
        • et al.
        Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort.
        Am J Med. 2014; 127: 295-302
        • Van de Werf F.
        • Bax J.
        • Betriu A.
        • et al.
        Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
        Eur Heart J. 2008; 29: 2909-2945
        • Bassand J.P.
        • Hamm C.W.
        • Ardissino D.
        • et al.
        Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.
        Eur Heart J. 2007; 28: 1598-1660
        • Schmidt M.
        • Maeng M.
        • Jakobsen C.J.
        • et al.
        Existing data sources for clinical epidemiology: the Western Denmark Heart Registry.
        Clin Epidemiol. 2010; 2: 137-144
        • Gaist D.
        • Sorensen H.T.
        • Hallas J.
        The Danish prescription registries.
        Dan Med Bull. 1997; 44: 445-448
        • Pedersen C.B.
        The Danish Civil Registration System.
        Scand J Public Health. 2011; 39: 22-25
        • Lam Q.
        • Black M.
        • Youdell O.
        • Spilsbury H.
        • Schneider H.G.
        Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay.
        Clin Chem. 2006; 52: 298-300
        • Braunwald E.
        Unstable angina. A classification.
        Circulation. 1989; 80: 410-414
        • Steg P.G.
        • Goldberg R.J.
        • Gore J.M.
        • et al.
        Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).
        Am J Cardiol. 2002; 90: 358-363
        • Chiang F.T.
        • Shyu K.G.
        • Wu C.J.
        • et al.
        Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry.
        J Formos Med Assoc. 2014; 113: 794-802
        • Wallentin L.
        • Becker R.C.
        • Budaj A.
        • et al.
        Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
        N Engl J Med. 2009; 361: 1045-1057
        • Hasdai D.
        • Behar S.
        • Wallentin L.
        • et al.
        A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).
        Eur Heart J. 2002; 23: 1190-1201
        • Marrugat J.
        • García M.
        • Elosua R.
        • et al.
        Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris).
        Am J Cardiol. 2004; 94: 1161-1165
        • Wiviott S.D.
        • Braunwald E.
        • McCabe C.H.
        • et al.
        Prasugrel versus clopidogrel in patients with acute coronary syndromes.
        N Engl J Med. 2007; 357: 2001-2015
        • André R.
        • Bongard V.
        • Elosua R.
        • et al.
        International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study.
        Heart. 2014; 100: 1201-1207
        • Terkelsen C.J.
        • Lassen J.F.
        • Nørgaard B.L.
        • et al.
        Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort.
        Eur Heart J. 2005; 26: 18-26
        • McManus D.D.
        • Gore J.
        • Yarzebski J.
        • Spencer F.
        • Lessard D.
        • Goldberg R.J.
        Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.
        Am J Med. 2011; 124: 40-47
        • Mendis S.
        • Thygesen K.
        • Kuulasmaa K.
        • et al.
        World Health Orginazation definition of myocardial infarction: 2008-09 revision.
        Int J Epidemiol. 2011; 40: 139-146
        • Nielsen K.M.
        • Foldspang A.
        • Larsen M.L.
        • Gerdes L.U.
        • Rasmussen S.
        • Faergeman O.
        Estimating the incidence of the acute coronary syndrome: data from a Danish cohort of 138 290 persons.
        Eur J Cardiovasc Prev Rehabil. 2007; 14: 608-614
        • Nikus K.C.
        • Eskola M.J.
        • Virtanen V.K.
        • et al.
        Mortality of patients with acute coronary syndromes still remains high: a follow-up study of 1188 consecutive patients admitted to a university hospital.
        Ann Med. 2007; 39: 63-71
        • Apple F.S.
        • Collinson P.O.
        Analytical characteristics of high-sensitivity cardiac troponin assays.
        Clin Chem. 2012; 58: 54-61
        • Apple F.S.
        A new season for cardiac troponin assays: it's time to keep a scorecard.
        Clin Chem. 2009; : 1303-1306
        • Aune E.
        • Hjemsæth J.
        • Fox K.A.
        • Endresen K.
        • Otterstad J.E.
        High mortality rates in conservatively managed patients with acute coronary syndrome.
        Scand Cardiovasc J. 2006; 40: 137-144
        • Mega J.L.
        • Braunwald E.
        • Wiviott S.D.
        • et al.
        Rivaroxaban in patients with a recent acute coronary syndrome.
        N Engl J Med. 2012; 366: 9-19
        • Vogel B.
        • Hahne S.
        • Kozanli I.
        • et al.
        Influence of updated guidelines on short- and long-term mortality in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).
        Int J Cardiol. 2012; 159: 198-204
        • Brown N.
        • Melville M.
        • Gray D.
        • et al.
        Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis.
        Heart. 1999; 81: 598-602
        • Bahit M.C.
        • Cannon C.P.
        • Antman E.M.
        • et al.
        Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.
        Am Heart J. 2003; 145: 109-117
        • Björklund E.
        • Lindahl B.
        • Stenestrand U.
        • et al.
        Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial.
        Am Heart J. 2004; 148: 566-573
        • Korley F.K.
        • Jaffe A.S.
        Preparing tke United States for high-sensitivity cardiac troponin assays.
        J Am Coll Cardiol. 2013; 61: 1753-1758
        • Lipinski M.J.
        • Baker N.C.
        • Escarcega R.O.
        • et al.
        Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis.
        Am Heart J. 2014; 169: 6-16.e6

      Linked Article

      • Troponinemia: An Area That Still Needs to Be Explored
        The American Journal of MedicineVol. 129Issue 2
        • Preview
          The research article by D'Souza et al,1 “Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays,” published in the August 2015 issue of The American Journal of Medicine is well supported by other clinical research evidence. I would like to add a few interesting pieces of information and get some clarification, which could add more weight to similar studies in the future.
        • Full-Text
        • PDF